baber/WOPTO huggingface dataset:
Patent NZ-337774-A (NZ)
Title: Encapsulation process and encapsulated products (pheromones) that modifies the behaviour of an animal for use in pest-control in forestry, horticulture or agriculture
Inventor: SENGUPTA ASHOK
IPC: A01N25/28
Filed: 1998-03-06
Abstract: A process for encapsulating a partially water-miscible organic material within a polyurea or polyurethane shell, which process comprises: (a) Providing an aqueous phase containing a surfactant; (b) Dispersing in the aqueous phase a water-immiscible organic solvent in which the partially water-miscible material to be encapsulated and a polyisocyanate are dissolved or dispersed, to form a dispersion of droplets of organic solvent in the continuous aqueous phase; (c) Adding to the dispersion a water-soluble tertiary amine; (d)Thereafter adding to the dispersion a polyfunctional compound containing functional group selected from the group consisting of primary amine, secondary amine and hydroxy groups, whereby there is formed discrete capsules composed of the material encapsulated in a polyurea or polyurethane shell. The application involves the encapsulation of materials that will modify the behaviour of animal species, for example semiochemicals such as pheromones, and their use for pest-control in forestry, agriculture or horticulture.
Patent NZ-501739-A (NZ)
Title: Plasticized aqueous coating compositions with a tertiary monocarboxylic acid as the plasticizer
Inventor: MAUER DAVID H
IPC: C09D201/00
Filed: 1998-06-24
Abstract: The aqueous coating composition, more particularly an aqueous floor finish composition, comprises water, at least one polymeric film forming agent, and a plasticizing agent, wherein at least a portion of the plasticizing agent is at least one tertiary alkyl monocarboxylic acid having an average of from about 6 to 30 carbon atoms per molecule. These compositions have one or more improved properties such as increased hardness as compared with the same compositions using only conventional plasticizers such as tributoxyethyl phosphate, improved wetting of the substrate by the composition during application, improved coating film leveling, improved multiple coat gloss development, and improved resistance to wear, black heel marking and scuffing.
Patent NZ-504774-A (NZ)
Title: Cellulosic fiber composites
Inventor: LAGACE ARTHUR
IPC: C08J5/04
Filed: 1998-10-26
Abstract: A composite comprising a resin and at least 2% by weight fibre, wherein the fibre is cellulosic or lignocellulosic fibre that has been sheared to the extent that the internal fibres are exposed. Also described is a process for manufacturing a composite, comprising shearing cellulosic or lignocellulosic fibre to the extent that its internal fibres are exposed to form texturized cellulosic fibre, and combining the texturized cellulosic or lignocellulosic fibre with a resin.
Patent NZ-506824-A (NZ)
Title: Regio-regular copolymer having a linear hydrocarbon polymer backbone with vicinal functional groups containing oxygen or nitrogen pendent from the backbone
Inventor: HUYNH-TRAN TRUE-CHI THI
IPC: C08G61/08
Filed: 1999-03-25
Abstract: A polymer product comprising a regio-regular vicinal functionalised polymer represented by the formula (III): wherein each X and Y independently represents a functional group, each R independently represents a hydrogen, C1 -C5 alkyl, or an X group, a and b each independently represents an integer of 0 to 6 provided that the sum of a+b is from 2 to 7 and n has a value of at least 10, and a method of preparation thereof. This polymer has a linear hydrocarbon polymer backbone with vicinal functional groups having oxygen and/or nitrogen atom containing groups, such as hydroxy, carboxylic acid or ester, carbonyl acetate, amide, nitrile and the like, pendent from the polymer backbone chain in a regio-regular manner.
Patent NZ-507927-A (NZ)
Title: A plurality of piles is provided which extends from the proximal end to the distal end and support the yarn from deflection to avoid sleaziness in a multi-layer fabric so that no layer can move relative to the other
Inventor: TROKHAN PAUL DENNIS
IPC: D21F11/00
Filed: 1999-06-09
Abstract: A woven papermaking belt having a paper contacting top surface plane (24) and an opposed backside (26). The belt comprises a fabric (22) having yarns disposed, in part, in the top surface plane to form knuckles (36). The belt further comprises reinforcing piles (40) extending from a proximal end (42) to a distal end (44). The distal ends (44) of the reinforcing piles (40) are disposed between the top surface plane (24) of the papermaking belt and the backside (26) of the papermaking belt. The reinforcing piles (40) resist applied loads and may prevent deflection of the knuckles (36) during the papermaking process. The applied loads may either be normal to the belt, as occurs during imprinting, within the plane of the belt, which causes sleaziness of the belt, or both. The belt may have piles (40) with proximal ends (42) disposed at two or more different elevations, as well as distal ends (44), which are disposed at two or more elevations. This arrangement provides a belt which imprint different densities onto paper during papermaking, according to the ability of the piles (40) to resist compressive loads applied normal to the plane of the belt. In one alternative embodiment, the piles (40) may be disposed between the first and second layers of a multi-layer papermaking belt. The belt is particularly suitable for woven papermaking fabrics having long, unsupported knuckles.
Patent NZ-508074-A (NZ)
Title: Biologically active compositions, and methods for their preparation, comprising a carrier matrix supersaturated with active agent
Inventor: BRYLAND RICKARD
IPC: A61K47/14
Filed: 1999-05-12
Abstract: A biologically active composition comprising a biologically active agent to be released therefrom.  The biologically active agent is dissolved and/or dispersed in a carrier, wherein the carrier is a liquid and/or solid non-crystalline matrix in which the biologically active agent is present in a supersaturated state.  This supersaturated state is obtainable by subjecting one or more carrier starting substance to such chemical operation(s) that the liquid and/or solid non-crystalline carrier matrix is provided in which the degree of saturation of the biologically active agent is higher than in the carrier starting substance, the biologically active agent being added before the chemical operation(s) has(have) been completed.
Patent NZ-510084-A (NZ)
Title: Fabric cleaning composition containing a non ionic surfactant and a zeolite MAP
Inventor: BEAGLE CHARLES
IPC: C11D3/12
Filed: 2000-07-07
Abstract: A free flowing granular cleaning composition for use in fabric care, comprising approximately by weight: (a)  5% to 20% ethoxylated non-ionic surfactant; (b)   2.5%  to  30%  zeolite having a silicon  to  aluminium weight ratio of less than 1.33; (c)  20% to 40% supplemental detergent builder salt; (d)  0.5% to 5% polyacrylate type polymer; (e)  0.5% to 35% sodium sulphate; and (f)  0.5% to 7% alkali metal silicate; wherein  the  composition does not contain an  alkali  metal salt of a fatty acid or a bleach compound.
Patent NZ-511032-A (NZ)
Title: Animal temperature sensing device including an ear tag having an animal and an ambient temperature sensors
Inventor: COOK CHRISTIAN JOHN
IPC: G01K13/00
Filed: 1999-10-26
Abstract: Disclosed is an animal temperature sensing device including an ear tag having an attachment portion to attach the ear tag to the animal, an animal temperature sensor disposed on/in the attachment portion to be in close contact with the animal during use, wherein the ear tag includes an ambient temperature sensor, wherein the ear tag includes a comparison means to compare the temperature between the animal temperature measured by the animal temperature sensor and the ambient temperature measured by the ambient temperature sensor and wherein the ear tag includes an indicator means responsive to the comparison means.
Patent NZ-523462-A (NZ)
Title: 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta and method of preparation thereof
Inventor: GONG LEYI
IPC: C07D405/14
Filed: 2001-07-18
Abstract: 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives of formula (I) and their pharmaceutically acceptable salts are disclosed, wherein: R1 and R2 independently represent hydrogen, alkyl, halogen, haloalkyl, alkylthio, hydroxy, alkoxy, cyano, nitro, amino, acylamino, monoalkylamino, or dialkylamino; R3 represents hydrogen, alkyl, cycloalkyl, heteralkyl, -COR7 (wherein R7 is hydrogen or alkyl), or phenyl optionally substituted with one or two substituents independently selected from the group consisting of hydrogen, alkyl, haloalkyl, alkylthio, hydroxy, alkoxy, cyano, nitro, amino, acylamino, monoalkylamino, and dialkylamino; R4 and R5 independently represent hydrogen, alkyl, halogen, haloalkyl, alkylthio, hydroxy, alkoxy, cyano, nitro, amino, acylamino, monoalkylamino, or dialkylamino; R6 is heteroalkyl, heterocyclyl, heterocyclylalkyl, heteroalkylsubstituted heterocyclyl, heteroalkylsubstituted cycloalkyl, heterosubstituted cycloalkyl, -OR8, -S(O)nR8 (wherein n = 0 to 2; and R8 is heteroalkyl, heteroaralkyl, heterocyclyl, or heterocyclylalkyl), -NR9R10 (wherein R9 is hydrogen or alkyl and R10 is heterosubstituted cycloalkyl, heteroalkyl, heteroaralkyl, heterocyclyl, or heterocyclylalkyl), or -X-(alkylene)-Y-Z (wherein X is a covalent bond, -O-, -NH-, or -S(O)n1- where n1 = 0 to 2, Y is -O-, NH-, or -S- and Z is heteroalkyl or SiR11(R12)(R13) where R11, R12 and R13 are independently hydrogen or alkyl.), or R6 together with R4 forms a methylenedioxy or ethylenedioxy group when they are adjacent to each other. The compounds of formula (I) are useful as inhibitors of glycogen synthase kinase-3b and, therefore, may be used for the treatment of GSK-3b mediated diseases such as Alzheimer's disease, obesity, diabetes, atherosclerotic cardiovascular disease, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer, allergy, and asthma in a mammal.
Patent NZ-525119-A (NZ)
Title: Propionic acid derivatives
Inventor: URBAHNS KLAUS
IPC: A61K31/341
Filed: 2001-09-24
Abstract: Compounds of the general formula (I) and processes for preparing them are disclosed. The compounds act as an antagonist of the peroxisome-proliferator-activated receptor and are useful in the treatment of coronary heart disease, arteriosclerosis, for increasing pathologically low HDL levels and for reducing elevated triglyceride and LDL levels in cases of arteriosclerosis and/or hypercholesterolaemia.
Patent NZ-526262-A (NZ)
Title: A latching mechanism
Inventor: WAITAI RANA JAMES
IPC: E05B55/00
Filed: 2001-12-13
Abstract: A latching mechanism for use with a lockset is disclosed. The mechanism has a housing and a snib (15) with lever. The snib (15) can be moved between latching and non-latching positions. A selector (33) is retained against movement with the snib (15) by retaining elements (45) engaged in recesses (48). The selector (33) can be moved to bring a recess (49) into alignment with a retaining element (45). Recess (49) is deeper than either of recesses (48) which permits the retaining element (45) engaged with recess (49) to move sufficiently an associated lock bolt (26) to engage with a bolt receiving portion (47) of the snib to thereby lock the snib against movement. The selector (33) can be adjusted to determine which of a pair of lock bolts (26) will engage with which bolt receiving portion so that the handling of the latching mechanism can be adjusted.
Patent NZ-527128-A (NZ)
Title: Primers and methods for the detection and discrimination of nucleic acids
Inventor: NAZARENKO IRINA
IPC: C12Q1/68
Filed: 2001-12-27
Abstract: A method is described, for distinguishing a single nucleotide polymorphism (SNP) in a target nucleic acid, which comprises: a) combining the target nucleic acid with a first internally labeled universal primer, a first allele specific primer, a second internally labeled universal primer, a second allele specific primer, and a common reverse or forward primer which hybridises to the target nucleic acid. The first and second labels are described to be different. The first allele specific primer has a 5' tail, which hybridises to the first universal primer, and a terminal 3' nucleotide that is specific to a first allele. The second allele specific primer is described to have a 5' tail, which hybridises to the universal primer, and a terminal 3' nucleotide that is specific to a second allele. This is explained to take place under conditions which allow extension of the allele specific primers; and b) detecting the first and second labels. The presence of the first label indicates the presence of the first allele, the presence of the second label indicates the presence of the second allele, and the presence of both labels indicates the presence of both alleles.
Patent NZ-528825-A (NZ)
Title: Mercaptoacetylamide derivatives, a process for their preparation and their use
Inventor: FLYNN GARY A
IPC: A61P9/00
Filed: 2002-04-03
Abstract: Mercaptoacetylamide derivatives of formula (I) are disclosed. Pharmaceutical compositions incorporating these compounds and processes for preparing said compounds are also disclosed. The compounds possess both angiotensin converting enzyme inhibitory activity and neutral endopeptidase inhibitory activity and are useful for the treatment of hypertension and congestive heart failure.
Patent NZ-532077-A (NZ)
Title: Indexable containers
Inventor: BLOMFIELD GREGORY THOMAS
IPC: B65D5/28
Filed: 2001-10-19
Abstract: A container formed from a blank of corrugated board where cuts between panels on a hinge axis (defined by hinging bridges (9)) reveal the flute ends (15 to 18) and thereby provide stack support for the base (1) of an indexing like container. Some of the blank material projects above at least one hinging bridge to form an indexing projection (11). (62) Divided out of 531197
Patent NZ-532496-A (NZ)
Title: A plate-type heat exchanger with single-walled and double-walled heat transfer plates
Inventor: REHBERG PETER
IPC: F28D9/00
Filed: 2004-04-23
Abstract: A plate-type heat exchanger (20) comprises a stack (21) of heat exchanger plates which are permanently interconnected and between which separate flow passage spaces are defined for at least two heat exchange fluids. One part of the heat exchanger plates is designed as single-walled heat exchanger plates each, having one plate member, while another part of the heat exchanger plates is designed as double-walled heat exchanger plates each, having two plate members.
Patent NZ-535105-A (NZ)
Title: Buoyancy garment in the form of a common garment with water safety features
Inventor: KEMP BRIAN ERNEST
IPC: A41D13/00
Filed: 2003-03-12
Abstract: A clothing item such as a shirt is combined with a concealed and entrapped bladder which can be inflated in the event of an emergency. The shirt can be of fashionable appearance and the buoyancy function disguised to make the buoyancy device more attractive to those who otherwise may be inclined to take risks on or in water.
Patent NZ-541338-A (NZ)
Title: computer-controlled arrangement for resting, feeding and milking animals
Inventor: JOHANSSON BJORN
IPC: A01K1/00
Filed: 2004-01-30
Abstract: An arrangement for housing a large number of milking animals, each of which belongs to one of a plurality of groups, comprises a resting area (1) wherein the milking animals are allowed to rest; a feeding area (3) wherein the milking animals are fed; and a milking area (5) housing at least one milking robot for milking the milking animals, wherein the resting area (1) or the feeding area (3) is partitioned in sections, the number of which corresponds to the number of the groups; and a device (53) is provided for directing each of the milking animals moving towards the resting area (1) or the feeding area (3), which is partitioned in sections, into one of the sections depending on the group, to which the respective milking animal belongs, so that each of said sections will house milking animals belonging to one of said groups.
Patent NZ-547498-A (NZ)
Title: Benzene compounds disubstituted with cyclic groups at the 1- and 2- positions
Inventor: KAWAHARA TETSUYA
IPC: C07D295/205
Filed: 2004-12-24
Abstract: Disclosed is a compound of formula (1), or a salt or hydrate thereof, wherein n is 0, 1, or 2, X1 is CH or N, R10 is a 5-10 membered cycloalkyl or cycloalkenyl, optionally substituted with a substituent from Group A1, two of R30, R31, and R32 may together form =O or -CH2-, or be separate substituents as described, R40 is C1-10alkyl optionally substituted with a substituent selected from group D1, and wherein the rest of the substituents are as described in the specification. Also disclosed is the use of the compound to treat inflammatory diseases, autoimmune diseases, inflammatory bowel disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma, atopic dermatitis, ulcerative colitis or Crohn's disease.
Patent NZ-548028-A (NZ)
Title: Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
Inventor: LEVERD ELIE
IPC: A61K9/08
Filed: 2004-12-17
Abstract: Disclosed is a vinflunine pharmaceutical composition, wherein it is in the form of a stable and sterile aqueous solution of a water-soluble vinflunine salt at a pH of between 3 and 4 and in that it does not contain any preservatives. In one embodiment the preferred vinflunine salt is vinflunine ditartrate and no buffer solution is added to the composition. The disclosure also relates to the method of preparing said composition and to the use thereof as a parenterally-administered medicament for the treatment of cancer.
Patent NZ-548235-A (NZ)
Title: Sulfonamide derivatives as beta2 agonists for the treatment of diseases
Inventor: BROWN ALAN DANIEL
IPC: C07D295/02
Filed: 2005-01-12
Abstract: Disclosed is a compound of formula (1), or a pharmaceutically acceptable salt, stereoisomer, tautomer, solvate, or isotopic variant thereof, wherein the ketone group is attached in the meta or para position, R1 and R2 are each H or C1-C4alkyl, n is 0, 1, or 2, and wherein Q1 is as defined in the specification. Also disclosed is the use of the compound to treat diseases in which the beta 2 receptor is involved. Also disclosed is a process for preparing the compound.
Patent NZ-549656-A (NZ)
Title: Non-capitalization weighted indexing system, method and computer program product
Inventor: ARNOTT ROBERT D
IPC: G06Q40/00
Filed: 2005-01-27
Abstract: A method and system to construct a valuation indifferent non-capitalization weighted index of performed assets is provided. The method includes the steps of: (a) gathering entity data about a plurality of assets; (b) selecting a plurality of the assets to create the valuation indifferent non-capitalization weighted index of assets based upon at least one objective measure of scale about one or more entities associated with the assets, wherein the selecting is exclusive of a material influence of a price of the assets; and (c) weighting the constituent assets of the valuation indifferent non-capitalization weighted index of assets via one of said processors to obtain constituent weightings based on at least one objective measure of scale regarding the entities associated with the assets, (d) wherein the weighting is exclusive of a material influence of the price of the assets; and wherein the weighting is not based on anyone of: equal weighting; weighting in proportion to the price of the assets; or weighting in proportion to market capitalization of the entities associated with the assets.
Patent NZ-550995-A (NZ)
Title: Improvements in slot machine games
Inventor: O'HALLORAN TERRY
Filed: 2006-11-02
Abstract: A method of operating a programmable slot machine adapted to display one or more reels, where each reel includes a plurality of symbols is disclosed. The method includes the steps of: (a) providing an associated set of two or more selectable reel strip configurations, wherein the probability of one or more of the symbols is changed between selectable reel strips, and (b) selecting one of the reel strip configurations from the set for use in a game.
Patent NZ-551073-A (NZ)
Title: A plug with a cap and projections for closing the outer end of a passage of a cast-in ferrule
Inventor: CONNELL ROBERT URQUHART
Filed: 2006-11-06
Abstract: A plug, for closing the outer end of a passage of a cast-in ferrule during casting of concrete around the ferrule, comprises a cap and structure 10 projecting from the cap to engage within the outer end of the ferrule passage. The cap is of an outwardly opening cupped form into which concrete is received and contained during casting.
Patent NZ-551444-A (NZ)
Title: Lift installation with equipment for compensation for the weight difference between cage runs and the counterweight runs of the support means and method for realisation of such compensation
Inventor: STALDER ROBERT
Filed: 2006-11-20
Abstract: A lift installation with at least one support means, which comprises at least one cage run supporting a lift cage and at least one counterweight run supporting a counterweight, is disclosed. A hanging cable with integrated conductors for transmission of energy and/or control signals is provided, and this is installed in the form of a hanging loop between a fixing point and the lift cage or the counterweight. Along the hanging cable, and fixed to its outside, weight elements are fixed to increase its weight per metre.
Patent NZ-551823-A (NZ)
Title: A delivery device for controlled release of drug
Inventor: RIIHIMAKI TEPPO
Filed: 2005-07-05
Abstract: Disclosed is a delivery system comprising a core and a membrane encasing said core, wherein said core and membrane consist essentially of an elastomer composition and said core comprises at least one therapeutically active agent. The delivery system is characterized in that the membrane comprises at least one regulating agent. The invention also relates to a method for controlling the release of at least one therapeutically active agent from a delivery system.
Patent NZ-555561-A (NZ)
Title: 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol (a Vitamin D derivative)
Inventor: DELUCA HECTOR F
Filed: 2005-11-18
Abstract: A compound of formula (I), or pharmaceutically acceptable salts thereof, wherein the subtituents are disclosed in the specification. Also disclosed is the suitability of the above compound for treating psoriasis, leukemia, colon cancer, breast cancer, prostate cancer, multiple sclerosis, lupus, diabetes mellitus, host versus graft reaction, rejection of organ transplants, an inflammatory disease selected from rheumatoid arthritis, asthma, or inflammatory bowel diseases such as celiac disease, ulcerative colitis and Crohn's disease, a skin condition selected from wrinkles, lack of adequate skin firmness, lack of adequate dermal hydration, or insufficient sebum secretion, renal osteodystrophy, or osteoporosis.